Earlier this week, the U.S. Food and Drug Administration held a meeting with several states to discuss the section 804 importation program (SIP) , which allows states and Indian tribes to import certain prescription drugs from Canada to significantly reduce the cost of these drugs to the American consumer.
The gathering was the latest step toward the FDA’s implementation of President’s Trump’s executive order on lowering drug prices. The meeting provided a forum to exchange information, with the goal of making it easier for states that have expressed interest in the program to obtain authorization without sacrificing safety or quality.
Representatives from HHS and the National Academy for State Health Policy also participated. “We are committed to lowering prescription drug prices for Americans, building on recent MFN wins,” said FDA Commissioner Marty Makary, M.D., M.P.H.
FDA News Releases published a clinical update in Research Highlights on 06 Mar 2026.
The item focuses on FDA Holds Meeting with States on Importation of Lower Cost Drugs.
Review the original article for the full source wording and details.